Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid Refractory GVHD”

126 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 126 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06075225
What this trial is testing

MAP-guided Preemptive Therapy of aGvHD by Ruxolitinib

Who this might be right for
GVHDAcute Stem Cell Transplant Complications
Sichuan University 62
Testing effectiveness (Phase 2)Looking for participantsNCT02918188
What this trial is testing

Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD

Who this might be right for
Chronic Graft-versus-host Disease
Navy General Hospital, Beijing 21
Testing effectiveness (Phase 2)Study completedNCT00388362
What this trial is testing

Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease

Who this might be right for
Graft vs Host Disease
Stanford University 36
Testing effectiveness (Phase 2)Study completedNCT02195869
What this trial is testing

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Pharmacyclics LLC. 45
Testing effectiveness (Phase 2)Study completedNCT02027805
What this trial is testing

Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD

Who this might be right for
Graft vs Host Disease
Xenikos 20
Early research (Phase 1)Looking for participantsNCT06568328
What this trial is testing

Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD

Who this might be right for
Graft vs Host Disease
Fujian Medical University 17
Testing effectiveness (Phase 2)UnknownNCT01549665
What this trial is testing

Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease

Who this might be right for
Graft-Versus-Host DiseaseGVHDAllogeneic Hematopoietic Transplant+1 more
Samsung Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00492921
What this trial is testing

High-Dose Cyclophosphamide for Steroid Refractory GVHD

Who this might be right for
Graft Versus Host Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Testing effectiveness (Phase 2)UnknownNCT04883918
What this trial is testing

ASC930 in Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)

Who this might be right for
Acute-graft-versus-host Disease
ASC Therapeutics 60
Testing effectiveness (Phase 2)UnknownNCT02519816
What this trial is testing

Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD

Who this might be right for
Chronic GVHD After HCT for Cancer or Immune Disease
daphne brockington 17
Testing effectiveness (Phase 2)Ended earlyNCT01903473
What this trial is testing

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Chronic Graft-Versus-Host DiseaseAcute Graft-Versus-Host DiseaseSteroid Refractory Graft-Versus-Host Disease
University of Liege 19
Testing effectiveness (Phase 2)UnknownNCT04189432
What this trial is testing

Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft-versus-host-disease
SCM Lifescience Co., LTD. 84
Testing effectiveness (Phase 2)Ended earlyNCT01226420
What this trial is testing

Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease

Who this might be right for
Chronic Graft-versus-host Disease
Dana-Farber Cancer Institute 6
Not applicableEnded earlyNCT04852692
What this trial is testing

Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD Participants

Who this might be right for
Chronic Graft vs Host Disease
Janssen Korea, Ltd., Korea 15
Testing effectiveness (Phase 2)Ended earlyNCT01898377
What this trial is testing

Imatinib Mesylate and Mycophenolate Mofetil for Steroid-Refractory Sclerotic/Fibrotic cGVHD in Children

Who this might be right for
Chronic Graft-versus-host Disease
Seoul National University Hospital 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT06075706
What this trial is testing

Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease

Who this might be right for
Steroid-refractory Acute Graft-versus-host Disease
medac GmbH 49
Testing effectiveness (Phase 2)Study completedNCT00201786
What this trial is testing

Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease

Who this might be right for
Graft-Versus-Host Disease
Ohio State University Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)Ended earlyNCT02322190
What this trial is testing

Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD

Who this might be right for
Chronic Graft vs. Host DiseaseGraft vs Host DiseaseGraft-Versus-Host Disease
National Cancer Institute (NCI) 5
Very early researchLooking for participantsNCT04744116
What this trial is testing

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmSteroid Refractory Graft Versus Host Disease
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Ended earlyNCT02993783
What this trial is testing

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Millennium Pharmaceuticals, Inc. 17
Load More Results